Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multi-centre, Double-blind Study, to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy

NCT00477295 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00477295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00477295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multi-centre, Double-blind Study, to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2007
Completion date
January 31, 2011
Enrollment
583 (actual)
Sites
79

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy